Our results are consistent with studies by Zhao et al. (2012[63]) who showed that bone marrow-derived MSCs were able to suppress CCl4 induced liver fibrosis through the high expression of MMP-2 and MMP-9. The gene discussed is MMP9; the disease is Hepatic fibrosis.